Keyphrases
Methylation
100%
Mesothelioma
100%
Malignant Mesothelioma
100%
P16INK4a Expression
100%
Tumor
42%
Gene Products
42%
P16INK4a
42%
Cytidine Analogues
42%
P16INK4a Gene
42%
Lung Cancer
28%
Mesothelioma Cells
28%
Clinical Significance
14%
Clinical Trials
14%
Molecular Mechanism
14%
Clinical Response
14%
Negative Regulator
14%
Malignancy
14%
Re-expression
14%
DNA Methylation (DNAm)
14%
Oncogenesis
14%
Neoplasms
14%
Potential Treatments
14%
Targeted Treatment
14%
Cell Growth
14%
Hypermethylation
14%
Tumor Samples
14%
DNA Hypermethylation
14%
Complete Response
14%
First Exons
14%
5-azacytidine
14%
Gene Methylation
14%
Combined Inactivation
14%
Product Expression
14%
Medicine and Dentistry
Methylation
100%
Mesothelioma
100%
Neoplasm
55%
Cell Line
33%
Gene Product
33%
Cytidine
33%
DNA Methylation
22%
Lung Cancer
22%
Clinical Trial
11%
Cancer
11%
Clinical Significance
11%
Carcinogenesis
11%
Exon
11%
Cell Growth
11%
5,6 Dihydroazacitidine
11%
Mesothelioma Cell Line
11%
Cyclin Dependent Kinase Inhibitor 2A
11%
Biochemistry, Genetics and Molecular Biology
Methylation
100%
Gene Product
50%
Cytidine
50%
DNA Methylation
33%
Clinical Trial
16%
Exon
16%
Carcinogenesis
16%
Cell Growth
16%
Azacitidine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Mesothelioma
100%
Neoplasm
50%
Cytidine
30%
Lung Cancer
20%
Clinical Trial
10%
Carcinogenesis
10%
5,6 Dihydroazacitidine
10%
Cyclin Dependent Kinase Inhibitor 2A
10%